Augmedix (AUGX) Stock Price, News & Analysis

Company Overview

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Key Stats

• Today's Range: $2.35 to $2.35
• 50-Day Range: $2.35 to $2.35
• 52-Week Range: $0.73 to $6.25
• Volume: N/A
• Average Volume: 635,746 shs
• Market Capitalization: $115.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AUGX Stock Analysis - Frequently Asked Questions

How have AUGX shares performed this year?

Augmedix's stock was trading at $2.35 at the beginning of 2025. Since then, AUGX shares have increased by 0.0% and is now trading at $2.35.
View the best growth stocks for 2025 here.

How were Augmedix's earnings last quarter?

Augmedix, Inc. (OTCMKTS:AUGX) posted its quarterly earnings data on Monday, March, 27th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.01. The firm had revenue of $8.75 million for the quarter, compared to the consensus estimate of $8.52 million. Augmedix had a negative net margin of 57.70% and a negative trailing twelve-month return on equity of 980.09%.

How do I buy shares of Augmedix?

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Augmedix own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include Meta Platforms (META), Urban Outfitters (URBN), Arista Networks (ANET), Capital Southwest (CSWC), NVIDIA (NVDA), PACCAR (PCAR) and Turkcell Iletisim Hizmetleri A.S. (TKC).

Company Calendar

• Last Earnings: 3/27/2023
• Today: 6/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:AUGX
• CIK: 1769804
• Web: www.augmedix.com
• Phone: 888-669-4885
• Fax: N/A
• Employees: 710
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$24.45 million
• Net Margins: -57.70%
• Pretax Margin: -57.23%
• Return on Equity: -980.09%
• Return on Assets: -57.85%

Debt

• Debt-to-Equity Ratio: 3.74
• Current Ratio: 1.70
• Quick Ratio: 1.70

Sales & Book Value

• Annual Sales: $51.58 million
• Price / Sales: 2.23
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.10 per share
• Price / Book: 23.50

Miscellaneous

• Outstanding Shares: 48,968,000
• Free Float: 36,316,000
• Market Cap: $115.07 million
• Optionable: Not Optionable
• Beta: -0.22